Incidence and predictors of rehospitalization of acute heart failure patients

International Heart Journal

Volumn 56, Issue 2, 2015, Pages 219-225

  Kaneko, Hidehiro ^a   Suzuki, Shinya ^a   Goto, Masato ^a   Arita, Takuto ^a   Yuzawa, Yasufumi ^a   Yagi, Naoharu ^a   Murata, Nobuhiro ^a   Kato, Yuko ^a   Kano, Hiroto ^a   Matsuno, Shunsuke ^a   Otsuka, Takayuki ^a   Uejima, Tokuhisa ^a   Oikawa, Yuji ^a   Sagara, Koichi ^a   Nagashima, Kazuyuki ^a   Kirigaya, Hajime ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a   Yajima, Junji ^a   Yamashita, Takeshi ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Diabetes mellitus; Diuretics; Elderly; Heart rate; Japanese

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; LOOP DIURETIC AGENT;

ACUTE HEART FAILURE; AGE; AGED; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; COMPARATIVE STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART RATE; HOSPITAL READMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; THORAX RADIOGRAPHY; ACUTE DISEASE; COHORT ANALYSIS; COMPLICATION; HEART FAILURE; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME; VERY ELDERLY;

ACUTE DISEASE; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HEART FAILURE; HEART RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; PATIENT READMISSION; RISK FACTORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS;

EID: 84929941457     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-290     Document Type: Article

References (54)

1. Gheorghiade M, Vaduganathan M, Fonarow GC, et al. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol 2013; 61: 391-403.
2. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update in-corporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1-90.
3. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009; 360: 1418-28.
4. Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, et al. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 1893-900.
5. Sato N, Kajimoto K, Asai K, et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J 2010; 159: 949-55.e1.
6. Tabata M, Shimizu R, Kamekawa D, et al. Six-minute walk dis-tance is an independent predictor of hospital readmission in pa-tients with chronic heart failure. Int Heart J 2014; 55: 331-6.
7. Tsuchihashi-Makaya M, Kinugawa S, Yokoshiki H, et al. Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival. Circ J 2010; 74: 1364-71.
8. Kaneko H, Suzuki S, Yajima J, et al. Clinical characteristics and long-term clinical outcomes of Japanese heart failure patients with preserved versus reduced left ventricular ejection fraction: a pro- spective cohort of Shinken Database 2004-2011. J Cardiol 2013; 62: 102-9.
9. Kaneko H, Suzuki S, Uejima T, et al. Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese pa-tients with symptomatic heart failure. Heart Vessels 2014; 29: 801-7.
10. Kaneko H, Suzuki S, Goto M, et al. Presentations and outcomes of patients with acute decompensated heart failure admitted in the winter season. J Cardiol (in press).
11. Kaneko H, Yajima J, Oikawa Y, et al. Recent characteristics and outcomes of Japanese stable angina pectoris after percutaneous coronary intervention. An observational cohort study using the Shinken Database. Int Heart J 2013; 54: 335-40.
12. Suzuki S, Yamashita T, Ohtsuka T, et al. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008; 72: 914-20.
13. Kaneko H, Koike A, Senoo K, et al. Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction. J Cardiol 2012; 59: 359-65.
14. Kaneko H, Yajima J, Oikawa Y, et al. Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study. J Cardiol 2013; 62: 18-24.
15. Kaneko H, Yajima J, Oikawa Y, et al. Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention. Heart Vessels 2014; 29: 156-64.
16. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-92.
17. Kaneko H, Yajima J, Oikawa Y, et al. Effects of statin treatment in patients with coronary artery disease and chronic kidney disease. Heart Vessels 2014; 29: 21-8.
18. Goda A, Yamashita T, Suzuki S, et al. Heart failure with preserved versus reduced left ventricular systolic function: a prospective cohort of Shinken Database 2004-2005. J Cardiol 2010; 55: 108-16.
19. Mebazaa A, Gheorghiade M, Piña IL, et al. Practical recommen-dations for prehospital and early in-hospital management of pa-tients presenting with acute heart failure syndromes. Crit Care Med 2008; 36: S129-39. (Review).
20. Joynt KE, Orav EJ, Jha AK. The association between hospital vol-ume and processes, outcomes, and costs of care for congestive heart failure. Ann Intern Med 2011; 154: 94-102.
21. Ross JS, Chen J, Lin Z, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2010; 3: 97-103.
22. Komajda M, Hanon O, Hochadel M, et al. Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I. Eur Heart J 2007; 28: 1310-8.
23. Mahjoub H, Rusinaru D, Soulière V, Durier C, Peltier M, Tribouil-loy C. Long-term survival in patients older than 80 years hospital-ised for heart failure. A 5-year prospective study. Eur J Heart Fail 2008; 10: 78-84.
24. Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J 2009; 30: 478-86.
25. Hamaguchi S, Kinugawa S, Goto D, et al. Predictors of long-term adverse outcomes in elderly patients over 80 years hospitalized with heart failure. - A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)-. Circ J 2011; 75: 2403-10.
26. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34: 29-34.
27. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001; 103: 2668-73.
28. Held C, Gerstein HC, Yusuf S, et al. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovas-cular risk. Circulation 2007; 115: 1371-5.
29. Control Group,Turnbull FM, Abraira C, Anderson RJ, et al. Inten-sive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52: 2288-98.
30. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update in-corporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: e391-479. (Review).
31. Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovas-cular disease. J Am Coll Cardiol 2007; 50: 823-30. (Review).
32. Ahmadi-Kashani M, Kessler DJ, Day J, et al. Heart rate predicts outcomes in an implantable cardioverter-defibrillator population. Circulation 2009; 120: 2040-5.
33. Böhm M, Swedberg K, Komajda M, et al. Heart rate as a risk fac-tor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010; 376: 886-94.
34. Heusch G. Heart rate and heart failure. Not a simple relationship. Circ J 2011; 75: 229-36. (Review).
35. Lechat P, Escolano S, Golmard JL, et al. Prognostic value of biso-prolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation 1997; 96: 2197-205.
36. Lechat P, Hulot JS, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001; 103: 1428-33.
37. Metra M, Torp-Pedersen C, Swedberg K, et al. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 2005; 26: 2259-68.
38. Konishi M, Haraguchi G, Kimura S, et al. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure. Circ J 2010; 74: 1127-34.
39. Sabbah HN, Sharov VG, Gupta RC, Todor A, Singh V, Goldstein S. Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure. J Am Coll Cardiol 2000; 36: 1698-705.
40. Chen G, Zhou X, Florea S, et al. Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis. Basic Res Cardiol 2010; 105: 573-81.
41. Leineweber K, Rohe P, Beilfuss A, et al. G-protein-coupled recep-tor kinase activity in human heart failure: effects of beta-adrenoceptor blockade. Cardiovasc Res 2005; 66: 512-9.
42. Brodde OE. Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure. Naunyn Schmiedebergs Arch Pharmacol 2007; 374: 361-72. (Review).
43. DiFrancesco D, Camm JA. Heart rate lowering by specific and se-lective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004; 64: 1757-65. (Review).
44. Chen PS, Joung B, Shinohara T, Das M, Chen Z, Lin SF. The ini-tiation of the heart beat. Circ J 2010; 74: 221-5. (Review).
45. Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010; 376: 875-85.
46. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46: e1-82. (Review).
47. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Interna- tional Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
48. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985; 103: 1-6.
49. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100: 1311-5.
50. López B, Querejeta R, González A, Sánchez E, Larman M, Díez J. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 2004; 43: 2028-35.
51. McCurley JM, Hanlon SU, Wei SK, Wedam EF, Michalski M, Haigney MC. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 2004; 44: 1301-7.
52. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007; 9: 1064-9.
53. Ahmed A, Husain A, Love TE, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 2006; 27: 1431-9.
54. Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, et al. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 2012; 76: 1920-7.